Gara Jalqabaatti › Obesity › Ohio › Cincinnati
Qorannoo klinikaalii Obesity Cincinnati, OH keessatti
Qorannoo 19 Obesity f Cincinnati fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Namoota walitti qabaa jiraSadarkaa 3
- Clinical Trial Investigator Clinical Research Center, Cincinnati
- Velocity Clinical Research - Cincinnati, Cincinnati
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
Namoota walitti qabaa jiraSadarkaa 3
- Velocity Clinical Research - Cincinnati, Cincinnati
- Velocity Clinical Research - Springdale, Cincinnati
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Namoota walitti qabaa jiraSadarkaa 3
- Velocity Clinical Research - Auburn, Cincinnati
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
Namoota walitti qabaa jiraSadarkaa 2
- CTI Clinical Research Center /ID# 282043, Cincinnati
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
Namoota walitti qabaa jiraSadarkaa 2
- Velocity Clinical Research, Cincinnati, Springdale, Cincinnati
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Namoota walitti qabaa jiraSadarkaa 3
- Midwest Eye Center, Cincinnati
- Velocity Clinical Research, Mt. Auburn, Cincinnati
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Namoota walitti qabaa jiraSadarkaa 3
- CTI Clinical Research Center, Cincinnati
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
Namoota walitti qabaa jiraSadarkaa 2
- CTI Clinical Research Center, Cincinnati
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Namoota walitti qabaa jiraSadarkaa 3
- CTI Clinical Research Center, Cincinnati
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Namoota walitti qabaa jiraSadarkaa 3
- AURORA-2 Clinical Site, Cincinnati
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Namoota walitti qabaa jiraSadarkaa 3
- AURORA-1 Clinical Site, Cincinnati
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
Namoota walitti qabaa jiraSadarkaa 3
- CTI Clinical Research Center, Cincinnati
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
Namoota walitti qabaa jiraSadarkaa 3
- CTI Clinical Research Center, Cincinnati
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Namoota walitti qabaa jiraSadarkaa 2
- CTI Clinical Research Center, Cincinnati
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
Namoota walitti qabaa jiraSadarkaa 2
- Cincinnati Children's Hospital Medical Center, Cincinnati
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Namoota walitti qabaa jiraSadarkaa 3
- Lindner Center,Christ Hospital, Cincinnati
A Single and Multiple Ascending Dose Study of HM17321 in Healthy and Obese Participants
Namoota walitti qabaa jiraSadarkaa 1Hojjettoota fayyaa simatamoo
- Medpace Clinical Pharmacology Unit, Cincinnati
Effects of Exercise on Lipids and Endothelial Function in Youth
Namoota walitti qabaa jira
- Cincinnati Children's Hospital Medical Center, Cincinnati
A Novel Obesity Prevention Program for High-Risk Infants in Primary Care
Namoota walitti qabaa jiraSadarkaa 2Hojjettoota fayyaa simatamoo
- Hopple Street Neighborhood Health Center, Cincinnati
Qorannoo Obesity magaalota biroo keessatti
- Houston, TXQorannoo 43
- Chicago, ILQorannoo 41
- New York City, NYQorannoo 40
- San Antonio, TXQorannoo 40
- Washington, DCQorannoo 33
- Orlando, FLQorannoo 32
- Dallas, TXQorannoo 30
- Boston, MAQorannoo 28
- Las Vegas, NVQorannoo 27
- Miami, FLQorannoo 27
- Baltimore, MDQorannoo 26
- Jacksonville, FLQorannoo 25
Qorannoo biroo Cincinnati keessatti
- Kansara Qara'a Non-Small CellQorannoo 35
- Saree (Gosoota Hunda)Qorannoo 27
- Saree OljooQorannoo 25
- Cufama OnneeQorannoo 24
- Kansarii ColorectalQorannoo 21
- Kansara MetastatikiiQorannoo 21
- Leukemia Myeloidii HamaaQorannoo 20
- Kansarii OvariiQorannoo 19
- Dhibee QaraQorannoo 19
- Kansarii ProstateQorannoo 18
- MelanomaQorannoo 17
- Myeloma Baay’eeQorannoo 17
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.